Diminished Antibody Response to Hepatitis B Immunization in Children With Sickle Cell Disease

Vaccination News Home Page

http://ipsapp003.lwwonline.com/content/getfile/3183/16/10/abstract.htm

 

Journal of Pediatric Hematology/Oncology 2002; 24(7):548-549

Diminished Antibody Response to Hepatitis B Immunization in Children With Sickle Cell Disease

Jeffrey Hord, M.D.; Beth Windsor, B.S.N.; Maria Koehler, M.D., Ph.D.; Julie Blatt, M.D.; Janine Janosky, Ph.D.; Joseph Mirro, M.D.

Summary:

Hepatitis B surface antibody titers were routinely measured in 150 children with sickle cell disease (SCD) after immunization, and the seroconversion rate was found to be lower than that in the general population (89% vs. 97%, P = 0.002). Most of the children who did not seroconvert after the series of 3 immunizations responded to booster injections (93%). Therefore, we recommend the measurement of hepatitis B surface antibody titers after immunization in those children with SCD at greatest risk for hepatitis B infection. An additional dose of hepatitis B vaccine should be administered to those without evidence of seroconversion.

Key Words: Immunity; Hepatitis; Sickle cell disease; Vaccine; Pediatrics

Submitted for publication November 1, 2001;

accepted December 10, 2001.

From the Departments of Pediatric Hematology/Oncology, Children's Hospital Medical Center of Akron, Akron, Ohio (J.H.); Pediatric Hematology/Oncology, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania (B.W.); Medical Oncology, Astrazeneca Pharmaceuticals, Wilmington, Delaware (M.K.); Pediatric Hematology/Oncology, University of North Carolina, Chapel Hill, North Carolina (J.B.); Family Medicine and Clinical Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania (J.J.); and St. Jude Children's Research Hospital, Memphis, Tennessee (J.M.).

Address correspondence and reprint requests to Jeffrey D. Hord, M.D., Division of Pediatric Hematology/Oncology, Children's Hospital Medical Center of Akron, One Perkins Square, Akron, OH 44308. E-mail: jhord@ chmca.org.

Journal of Pediatric Hematology/Oncology 2002; 24(7):548-549
All rights reserved

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.